Correlation Between Krystal Biotech and Vir Biotechnology

Can any of the company-specific risk be diversified away by investing in both Krystal Biotech and Vir Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krystal Biotech and Vir Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Krystal Biotech and Vir Biotechnology, you can compare the effects of market volatilities on Krystal Biotech and Vir Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krystal Biotech with a short position of Vir Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krystal Biotech and Vir Biotechnology.

Diversification Opportunities for Krystal Biotech and Vir Biotechnology

0.39

Correlation Coefficient

Krystal Biotech  Vir Biotechnology

Weak diversification

The 3 months correlation between Krystal and Vir is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Krystal Biotech and Vir Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vir Biotechnology and Krystal Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krystal Biotech are associated (or correlated) with Vir Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vir Biotechnology has no effect on the direction of Krystal Biotech i.e., Krystal Biotech and Vir Biotechnology go up and down completely randomly.

Pair Corralation between Krystal Biotech and Vir Biotechnology

Given the investment horizon of 90 days Krystal Biotech is expected to generate 0.64 times more return on investment than Vir Biotechnology. However, Krystal Biotech is 1.56 times less risky than Vir Biotechnology. It trades about -0.03 of its potential returns per unit of risk. Vir Biotechnology is currently generating about -0.02 per unit of risk. If you would invest  18,227  in Krystal Biotech on September 27, 2024 and sell it today you would lose (2,375) from holding Krystal Biotech or give up 13.03% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Krystal Biotech  vs.  Vir Biotechnology

Krystal Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Krystal Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Vir Biotechnology

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Vir Biotechnology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable forward indicators, Vir Biotechnology is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Krystal Biotech and Vir Biotechnology

The main advantage of trading using opposite Krystal Biotech and Vir Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krystal Biotech position performs unexpectedly, Vir Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vir Biotechnology will offset losses from the drop in Vir Biotechnology's long position.

The idea behind Krystal Biotech and Vir Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.